 The Center for the Chronic Myeloproliferative Disorders was established to meet the clinical needs of patients with Polycythemia Vera (PV), Idiopathic Myelofibrosis (IMF), Essential Thrombocytosis (ET), Systemic Mastocytosis (SM) and the Hypereosinophilic Syndrome (HES), while addressing the mechanisms involved in the causation of these disorders. Building on fifty years of clinical experience in the management of the chronic myeloproliferative disorders within the Hematology Division at Johns Hopkins, as well as on active basic and clinical research programs dedicated to these diseases, the Center for the Chronic Myeloproliferative Disorders provides in one setting comprehensive consultation for PV, IMF, ET, SM and HES patients. The consultation begins with an evaluation by a Center hematologist and involves as necessary collaborating physicians from the disciplines of Surgery, Dermatology, Nuclear Medicine, Pathology, Pediatrics, Bone Marrow Transplantation, Transfusion Medicine and Obstetrics. The intent of the Center is to facilitate access to all the medical, surgical and laboratory evaluations that patients may require in order to provide them and their physicians with a consensus opinion with respect to diagnosis and management. The chronic myeloproliferative disorders are compatible with substantial longevity if care is exercised in their management. However, these disorders are uncommon, not always easy to recognize and there is no uniformity concerning either their diagnosis or their management. The mission of the Center for the Chronic Myeloproliferative Disorders is to improve the understanding of these unique disorders with respect to their pathogenesis, diagnosis and treatment through basic and clinical research. |
 |
 |
Ross 1025 720
Rutland AvenueBaltimore,
MD 21205(410)
955-7417© 2001 Johns Hopkins University School of Medicine |